Jump Financial, LLC Arcutis Biotherapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.32 - $11.0 $1.26 Million - $1.67 Million	-151,385 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $606,617 - $1.05 Million	83,787 Added 123.95%	151,385 $1.41 Million
Q1 2024 May 13, 2024	BUY	$3.25 - $11.77 $219,693 - $795,628	67,598 New	67,598 $669,000
Q3 2023 Oct 21, 2024	SELL	$5.31 - $10.98 $120,154 - $248,455	-22,628 Reduced 52.73%	20,286 $107,000
Q3 2023 Nov 07, 2023	BUY	$5.31 - $10.98 $107,718 - $222,740	20,286 New	20,286 $107,000
Q1 2023 Oct 21, 2024	SELL	$10.23 - $17.14 $1.11 Million - $1.86 Million	-108,471 Reduced 71.65%	42,914 $472,000
Q1 2023 May 03, 2023	BUY	$10.23 - $17.14 $25,933 - $43,449	2,535 Added 6.28%	42,914 $472,000
Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $563,690 - $823,731	40,379 New	40,379 $597,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $825M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.